Wuxi Apptec
Wuxi Apptec, a leading global contract research, development, and manufacturing organisation (CRDMO), is headquartered in Wuxi, China. Founded in 2000, the company has expanded its operational footprint across North America, Europe, and Asia, establishing itself as a key player in the biopharmaceutical industry. Wuxi Apptec offers a comprehensive suite of services, including drug discovery, development, and manufacturing, which are distinguished by their innovative technologies and commitment to quality. The company has achieved significant milestones, such as the establishment of multiple state-of-the-art facilities and a robust portfolio of partnerships with major pharmaceutical firms. Recognised for its market leadership, Wuxi Apptec continues to drive advancements in the life sciences sector, providing essential support to clients in bringing new therapies to market efficiently and effectively.
DitchCarbon Score
How does Wuxi Apptec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Wuxi Apptec's score of 53 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Wuxi Apptec's reported carbon emissions
In 2023, Wuxi Apptec reported total carbon emissions of approximately 680,373,980 kg CO2e, comprising 68,853,620 kg CO2e from Scope 1, 467,798,350 kg CO2e from Scope 2, and 143,722,000 kg CO2e from Scope 3 emissions. This marked a slight increase from the previous year, where total emissions were about 677,626,400 kg CO2e in 2022. Wuxi Apptec has set a significant commitment to reduce its greenhouse gas (GHG) emissions intensity by 25% by 2030, starting from 2023. This target encompasses all scopes of emissions, reflecting the company's proactive approach to combat climate change within the pharmaceuticals, biotechnology, and life sciences sector. The company has consistently disclosed its emissions data, focusing on both Scope 1 and Scope 2 emissions, while also addressing Scope 3 emissions, which include indirect emissions from sources such as business travel and purchased goods and services. This comprehensive reporting aligns with industry standards and demonstrates Wuxi Apptec's commitment to transparency and sustainability in its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 6,643,770 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 144,938,320 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wuxi Apptec is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
